Common drug ivermectin tested in new fight against aggressive breast cancer
Disease control
Recruiting now
This early-stage study is testing whether adding the drug ivermectin to standard immunotherapy helps shrink tumors in people with advanced triple-negative breast cancer that has spread. The main goals are to find a safe dose and see if the combination is more effective than immun…
Phase: PHASE1, PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC